IBB News and Press, iShares Biotechnology ETF From 04/13/23

2023-04-13 08:01:47 ET Summary MorphoSys completed enrollment for MANIFEST-2, a Phase 3 study exploring the safety and efficacy of pelabresib in combination with ruxolitinib for JAK inhibitor-naïve patients with myelofibrosis. The topline data of the MANIFEST-2 is expected by...

2023-04-12 16:31:23 ET Summary Structure Therapeutics has a promising pipeline of product candidates, including GSBR-1290, a GLP-1R agonist for diabetes and obesity, and APJR and LPA1R agonists and antagonists for various indications. The company has several competitive advantages...

2023-04-12 02:26:28 ET Summary The White House's announcement on drug price caps caused a significant drop in biopharma stocks during Q1 2023. The impact of drug pricing-related caps and pressure will likely be limited, and the industry is expected to adapt and find new revenue st...

2023-04-10 08:26:10 ET Summary GSK's dividend yield is 3.58%, slightly higher than Bristol-Myers Squibb's 3.22%. Bristol-Myers Squibb's total debt was about $40.8 billion at the end of 2022, down $4.78 billion from the previous year, thanks to the successful integration of Celgene...

2023-04-06 23:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-03-30 00:12:45 ET Summary RAPT Therapeutics, Inc. is a clinical-stage biotech developer of specific small molecules that can modulate the critical immune drivers of inflammatory diseases and oncology. The pipeline of investigational therapies includes FLX475 as a potential tr...

2023-03-28 13:35:57 ET Summary The Biotech space has not caught much of a tailwind from lower interest rates lately. After a stellar relative return in the second half of 2022, the trend has turned in favor of the bears. I outline key price levels to monitor following a bearis...

2023-03-28 08:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-03-28 07:31:34 ET Summary IBB invests in biotechnology stocks predominantly in the United States. The healthcare sector is renowned for its relative stability during market fluctuations compared to that of more procyclical alternatives in sectors like financials and technolog...

2023-03-25 08:41:03 ET Summary XBI sits 58% below its all-time high. Yet I still don't think it is a good investment here. There are too many risk factors for the smaller biotech stocks this ETF owns, and tighter lending conditions will only complicate things. I rate XBI ETF a...